Diuretic Resistance in Heart Failure.

Area of Science:

• Cardiology
• Nephrology
• Pharmacology

Background:

• Decompensated heart failure leads to over 1 million US hospitalizations annually, with increasing prevalence.
• Fluid overload is a primary concern, typically managed with diuretics.
• Diuretic resistance presents a significant therapeutic challenge in heart failure management.

Purpose of the Study:

• To review the challenges and therapeutic strategies for managing diuretic resistance in heart failure.
• To explore the prevalence, predictive factors, and pathophysiology of diuretic resistance.
• To outline current and potential treatment approaches for this condition.

Main Methods:

• Literature review of studies on diuretic resistance in heart failure.
• Analysis of factors predicting diuretic resistance, including clinical and laboratory parameters.
• Synthesis of information on the multifactorial pathophysiology, including pharmacokinetic and hormonal aspects.
• Overview of therapeutic interventions, including dose adjustments, sequential nephron blockade, and mechanical fluid removal.

Main Results:

• Diuretic resistance affects an estimated 25-30% of heart failure patients.
• Predictive factors include low systolic blood pressure, renal impairment, and atherosclerotic disease.
• Pathophysiology involves pharmacokinetic changes, hormonal imbalances, and cardiorenal syndrome.
• Treatment strategies include dose escalation, sequential nephron blockade, ultrafiltration, and paracentesis.

Conclusions:

• Diuretic resistance is a complex and common complication in decompensated heart failure.
• Understanding predictive factors and pathophysiology is crucial for effective management.
• A multi-pronged therapeutic approach is often necessary to overcome diuretic resistance and manage fluid overload.